| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |